These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 23165507)

  • 21. Is human T-lymphotropic virus type 1 infection associated with hearing loss?
    Bakhshaee M; Sorouri A; Shoeibi A; Boustani R; Golhasani-Keshtan F; Amali A; Rajati M
    Laryngoscope; 2015 Apr; 125(4):956-60. PubMed ID: 25354174
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-Tax antibody levels in asymptomatic carriers, oligosymptomatic carriers, patients with rheumatologic disease or with HAM/TSP do not correlate with HTLV-1 proviral load.
    de Souza JG; da Fonseca FG; Martins ML; Martins CP; de Carvalho LD; Coelho-dos-Reis JG; Carneiro-Proietti AB; Martins-Filho OA; Barbosa-Stancioli EF;
    J Clin Virol; 2011 Jan; 50(1):13-8. PubMed ID: 20951636
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential patterns of serum biomarkers of immune activation in human T-cell lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis, and adult T-cell leukemia/lymphoma.
    Giusti RM; Maloney EM; Hanchard B; Morgan OS; Steinberg SM; Wachter H; Williams E; Cranston B; Fuchs D; Manns A
    Cancer Epidemiol Biomarkers Prev; 1996 Sep; 5(9):699-704. PubMed ID: 8877061
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Possible implication of NFKB1A and NKG2D genes in susceptibility to HTLV-1-associated myelopathy/tropical spastic paraparesis in Peruvian patients infected with HTLV-1.
    Talledo M; López G; Huyghe JR; Verdonck K; González E; Clark D; Vanham G; Gotuzzo E; Van Camp G; Van Laer L
    J Med Virol; 2012 Feb; 84(2):319-26. PubMed ID: 22170554
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Keratoconjunctivitis sicca of human T cell lymphotropic virus type 1 (HTLV-1) infected individuals is associated with high levels of HTLV-1 proviral load.
    Castro-Lima Vargens C; Grassi MF; Boa-Sorte N; Rathsam-Pinheiro RH; Olavarria VN; de Almeida Kruschewsky R; Galvão-Castro B
    J Clin Virol; 2011 Nov; 52(3):177-80. PubMed ID: 21868282
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Natural history of human T-lymphotropic virus 1-associated myelopathy: a 14-year follow-up study.
    Olindo S; Cabre P; Lézin A; Merle H; Saint-Vil M; Signate A; Bonnan M; Chalon A; Magnani L; Cesaire R; Smadja D
    Arch Neurol; 2006 Nov; 63(11):1560-6. PubMed ID: 17101824
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pathophysiology, treatment and biomarkers for HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP)].
    Yamano Y; Sato T
    Nihon Rinsho; 2013 May; 71(5):870-5. PubMed ID: 23777097
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral manifestations of human T-cell lymphotropic virus infection in adult patients from Brazil.
    Martins FM; Casseb J; Penalva-de-Oliveira AC; de Paiva MF; Watanuki F; Ortega KL
    Oral Dis; 2010 Mar; 16(2):167-71. PubMed ID: 20374504
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Immunopathogenesis and treatment of the myelopathy associated to the HTLV-I virus].
    Carod-Artal FJ
    Rev Neurol; 2009 Feb 1-15; 48(3):147-55. PubMed ID: 19206063
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and demographic features of HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Rio de Janeiro, Brazil.
    Araújo Ade Q; Alfonso CR; Schor D; Leite AC; de Andrada-Serpa MJ
    Acta Neurol Scand; 1993 Jul; 88(1):59-62. PubMed ID: 8372632
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Testing the vestibular evoked myogenic potential (VEMP) to identify subclinical neurological alterations in different phases of human T-lymphotropic virus type 1 infection.
    Felipe L; Kingma H; Lambertucci JR; Carneiro-Proietti AB; Gonçalves DU
    Spine J; 2013 Apr; 13(4):397-401. PubMed ID: 23267739
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Seroprevalence of HTLV-I in relatives of patients with spastic paraparesis (HAM/TSP and PEP)].
    Cartier L; Vergara C; Ramírez E; Casivar T; Vásquez A
    Rev Med Chil; 1995 Jan; 123(1):7-11. PubMed ID: 7569448
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disulfide-mediated apoptosis of human T-lymphotrophc virus type-I (HTLV-I)-infected cells in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis.
    Nishiura Y; Nakamura T; Fukushima N; Nakamura H; Ida H; Aramaki T; Eguchi K
    Antivir Ther; 2009; 14(4):533-42. PubMed ID: 19578238
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Erectile dysfunction and HTLV-I infection: a silent problem.
    Castro N; Oliveira P; Freitas D; Rodrigues W; Muniz A; Carvalho E
    Int J Impot Res; 2005; 17(4):364-9. PubMed ID: 15875060
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation between polymorphisms at interleukin-6 but not at interleukin-10 promoter and the risk of human T lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis in Brazilian individuals.
    Gadelha SR; Junior Alcântara LC; Costa GC; Acosta AX; Rios D; Kashima S; Covas DT; Galvão-Castro B
    J Med Virol; 2008 Dec; 80(12):2141-6. PubMed ID: 19040291
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polymorphisms at GLUT1 gene are not associated with the development of TSP/HAM in Brazilian HTLV-1 infected individuals and the discovery of a new polymorphism at GLUT1 gene.
    Costa GC; Azevedo R; Gadelha SR; Kashima SH; Muricy G; Olavarria VN; Covas DT; Takayanagui OM; Galvão-Castro B; Alcantara LC
    J Med Virol; 2009 Mar; 81(3):552-7. PubMed ID: 19152396
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Temporal dynamics of human T-lymphotropic virus type I tax mRNA and proviral DNA load in peripheral blood mononuclear cells of human T-lymphotropic virus type I-associated myelopathy patients.
    Ramirez E; Cartier L; Torres M; Barria M
    J Med Virol; 2007 Jun; 79(6):782-90. PubMed ID: 17457906
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human T lymphotropic virus type I (HTLV-I) proviral load in cerebrospinal fluid: a new criterion for the diagnosis of HTLV-I-associated myelopathy/tropical spastic paraparesis?
    Lezin A; Olindo S; Oliere S; Varrin-Doyer M; Marlin R; Cabre P; Smadja D; Cesaire R
    J Infect Dis; 2005 Jun; 191(11):1830-4. PubMed ID: 15871115
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The current and future approaches to the treatment of HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP)].
    Yamano Y; Sato T; Ando H; Araya N; Yagishita N
    Nihon Rinsho; 2012 Apr; 70(4):705-13. PubMed ID: 22568157
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of killer cell immunoglobulin-like receptor gene content and human leukocyte antigen-C group in susceptibility to human T-lymphotropic virus 1-associated myelopathy/tropical spastic paraparesis in Peru.
    Talledo M; López G; Huyghe JR; Verdonck K; González E; Clark D; Senitzer D; Vanham G; Gotuzzo E; Van Camp G; Van Laer L
    Hum Immunol; 2010 Aug; 71(8):804-8. PubMed ID: 20483367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.